Literature DB >> 22035250

The role of sexually transmitted infections in the evolution of the South African HIV epidemic.

Leigh F Johnson1, Rob E Dorrington, Debbie Bradshaw, David J Coetzee.   

Abstract

OBJECTIVES: To assess the extent to which sexually transmitted infections (STIs) have contributed to the spread of HIV in South Africa and to estimate the extent to which improvements in STI treatment have reduced HIV incidence.
METHODS: A mathematical model was used to simulate interactions between HIV and six other STIs (genital herpes, syphilis, chancroid, gonorrhoea, chlamydial infection and trichomoniasis) as well as bacterial vaginosis and vaginal candidiasis. The effects of STIs on HIV transmission probabilities were assumed to be consistent with meta-analytic reviews of observational studies, and the model was fitted to South African HIV prevalence data.
RESULTS: The proportion of new HIV infections in adults that were attributable to curable STIs reduced from 39% (uncertainty range: 24-50%) in 1990 to 14% (8-18%) in 2010, while the proportion of new infections attributable to genital herpes increased. Syndromic management programmes are estimated to have reduced adult HIV incidence by 6.6% (3.3-10.3%) between 1994 and 2004, by which time syndromic management coverage was 52%. Had syndromic management been introduced in 1986, with immediate achievement of 100% coverage and a doubling of the rate of health seeking, HIV incidence would have reduced by 64% (36-82%) over the next decade, but had the same intervention been delayed until 2004, HIV incidence would have reduced by only 5.5% (2.8-9.0%).
CONCLUSIONS: Sexually transmitted infections have contributed significantly to the spread of HIV in South Africa, but STI control efforts have had limited impact on HIV incidence because of their late introduction and suboptimal coverage.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 22035250     DOI: 10.1111/j.1365-3156.2011.02906.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  14 in total

1.  Inflammatory cytokine biomarkers to identify women with asymptomatic sexually transmitted infections and bacterial vaginosis who are at high risk of HIV infection.

Authors:  Lindi Masson; Kelly B Arnold; Francesca Little; Koleka Mlisana; David A Lewis; Nonhlanhla Mkhize; Hoyam Gamieldien; Sinaye Ngcapu; Leigh Johnson; Douglas A Lauffenburger; Quarraisha Abdool Karim; Salim S Abdool Karim; Jo-Ann S Passmore
Journal:  Sex Transm Infect       Date:  2015-10-28       Impact factor: 3.519

Review 2.  Genital inflammation, immune activation and risk of sexual HIV acquisition.

Authors:  Jo-Ann S Passmore; Heather B Jaspan; Lindi Masson
Journal:  Curr Opin HIV AIDS       Date:  2016-03       Impact factor: 4.283

3.  The effect of changes in condom usage and antiretroviral treatment coverage on human immunodeficiency virus incidence in South Africa: a model-based analysis.

Authors:  Leigh F Johnson; Timothy B Hallett; Thomas M Rehle; Rob E Dorrington
Journal:  J R Soc Interface       Date:  2012-01-18       Impact factor: 4.118

4.  Vaginal colonisation by probiotic lactobacilli and clinical outcome in women conventionally treated for bacterial vaginosis and yeast infection.

Authors:  Sonal Pendharkar; Erik Brandsborg; Lennart Hammarström; Harold Marcotte; Per-Göran Larsson
Journal:  BMC Infect Dis       Date:  2015-07-03       Impact factor: 3.090

5.  High human papillomavirus (HPV) prevalence in South African adolescents and young women encourages expanded HPV vaccination campaigns.

Authors:  Zizipho Z A Mbulawa; Cari van Schalkwyk; Nai-Chung Hu; Tracy L Meiring; Shaun Barnabas; Smritee Dabee; Heather Jaspan; Jean-Mari Kriek; Shameem Z Jaumdally; Etienne Muller; Linda-Gail Bekker; David A Lewis; Janan Dietrich; Glenda Gray; Jo-Ann S Passmore; Anna-Lise Williamson
Journal:  PLoS One       Date:  2018-01-02       Impact factor: 3.240

6.  Prevalence and risk factors associated with sexually transmitted infections (STIs) among women of reproductive age in Swaziland.

Authors:  Themba G Ginindza; Cristina D Stefan; Joyce M Tsoka-Gwegweni; Xolisile Dlamini; Pauline E Jolly; Elisabete Weiderpass; Nathalie Broutet; Benn Sartorius
Journal:  Infect Agent Cancer       Date:  2017-05-25       Impact factor: 2.965

7.  Modelling the human immunodeficiency virus (HIV) epidemic: A review of the substance and role of models in South Africa.

Authors:  Nathan Geffen; Alex Welte
Journal:  South Afr J HIV Med       Date:  2018-02-21       Impact factor: 2.744

Review 8.  Recent Advances and New Challenges in Cisgender Women's Gynecologic and Obstetric Health in the Context of HIV.

Authors:  Jennifer Deese; Renee Heffron; Heather Jaspan; Lindi Masson; Jennifer A Smit; Sengeziwe Sibeko
Journal:  Clin Obstet Gynecol       Date:  2021-09-01       Impact factor: 1.966

9.  Modelling the impact of chlamydia screening on the transmission of HIV among men who have sex with men.

Authors:  Maria Xiridou; Henrike J Vriend; Anna K Lugner; Jacco Wallinga; Johannes S Fennema; Jan M Prins; Suzanne E Geerlings; Bart J A Rijnders; Maria Prins; Henry J C de Vries; Maarten J Postma; Maaike G van Veen; Maarten F Schim van der Loeff; Marianne A B van der Sande
Journal:  BMC Infect Dis       Date:  2013-09-18       Impact factor: 3.090

10.  Prevalence and risk factors of three curable sexually transmitted infections among women in Nairobi, Kenya.

Authors:  Anne Njeri Maina; Joshua Kimani; Omu Anzala
Journal:  BMC Res Notes       Date:  2016-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.